Press Releases

Let's spread the word about Immunotherapy! Click to share this page with your community.
June 28, 2019

CRI and Chordoma Foundation Partner

CRI and Chordoma Foundation announced today that they have established a research partnership to advance treatment options for chordoma, an ultra-rare cancer in the sarcoma family.

June 21, 2019

CRI Hosts Inaugural “Immuno-Oncology: A Future Look”

Discussion of the next wave of scientific advancements in immuno-oncology by panel of industry and academic leaders

June 21, 2019

New STARs of Cancer Immunotherapy Research

Five U.S. scientists have been awarded $1.25 million each to carry out high-risk, high-reward cancer immunology research with potential to transform cancer treatment.

May 21, 2019

CRI Champions Cancer Immunotherapy Month

30 days of immunotherapy education and awareness programming for patients, caregivers, and the general public celebrating advances in immuno-oncology research and treatment

November 28, 2018

Growth in Global Clinical Trial Landscape for PD-1/L1 Checkpoint Inhibitors

Cancer Research Institute has published a comprehensive analysis of the current clinical trial landscape of anti PD-1/L1 immune checkpoint inhibitors.

*Immunotherapy results may vary from patient to patient.